Sema4 Press Release | 1.14.201

Sema4 Appoints Renowned Oncologist William Oh, M.D. as Chief Medical Science Officer

Dr. William Oh, an internationally recognized medical oncologist, has joined Sema4 as Chief Medical Science Officer. Dr. Oh brings more than 25 years of clinical and translational research experience.
Sema4 Press Release | 12.17.20

Merus and Sema4 Enter Into an Agreement to Support Merus’ Phase 1/2 Clinical Trial of Zenocutuzumab

Merus and Sema4 are utilizing Sema4’s genomic testing to identify patients with tumors harboring neuregulin 1 gene fusions who may be eligible for investigational treatment with the bispecific antibody Zenocutuzumab in a trial sponsored by Merus.
Cancer Network | 12.11.20

Eric Schadt, Ph.D., on Predicting Disease Risk for Patients with Cancer

Cancer Network conducted a video interview with Sema4 Founder & CEO Eric Schadt. Among other things, Dr. Schadt discusses Sema4’s data-driven precision oncology solutions and the difference they make for healthcare providers and their patients.
Indiana University | 12.10.20

Nationwide Study into COVID-19 Infection, Reinfection, Immunity Backed by Philanthropic Investment

Sema4 is participating in a nationwide research study on COVID-19. Led by the Indiana University School of Public Health, Sema4 Founder & CEO Eric Schadt is part of the multi-institutional study’s team of investigators.
Hartford Business Journal | 12.9.20

Bioscience Group Recognizes Healthtech Entrepreneur

The Hartford Business Journal covered BioCT’s naming Sema4 Founder & CEO Eric Schadt as its 2020 Entrepreneur of the Year. The story highlighted Sema4’s growth as a key winning factor for the recognition and provided more background information on the award.
BioCT | 12.9.20

Eric Schadt, Founder & CEO of Sema4, Named 2020 BioCT Entrepreneur of the Year

BioCT has recognized Eric Schadt as its Entrepreneur of the Year. Among other things, those recommending Dr. Schadt for the award wrote that he is “one of the great biotech minds in the country.”
Clinical OMICs | 12.08.20

Conversation with Eric Schadt, CEO, Sema4

Clinical OMICs published an extensive Q&A featuring Eric Schadt, Founder and CEO of Sema4. The article covers the origins of Sema4, the company’s current priorities, its focus on data-driven solutions to improve health outcomes, and more.
NBC Connecticut | 12.3.20

Sema4 to Move Lab from New York to Connecticut, Add 200 Jobs

NBC Connecticut interviewed Sema4 President & COO Jamie Coffin on the opening of Sema4’s new 70,000 square foot facility in Stamford, CT. Among other things, the story covered Sema4’s growth and the jobs the company is generating in Connecticut.
Hartford Courant | 12.3.20

Sema4, a Health Data Company, Expands in Stamford as Demand Grows for Genetic Research and Personal Medicine

The Hartford Courant covered Sema4’s announcement on its opening of its newly built clinical laboratory in Connecticut. The feature story profiled Sema4’s continued expansion, the surge in demand for data-driven healthcare, and more.
Westchester and Fairfield County Business Journals | 12.3.20

Sema4 Opens 70,000-square-foot Clinical Lab in Stamford

Westchester and Fairfield County Business Journals highlighted Sema4’s opening of its second clinical laboratory in Connecticut. The outlet noted that the new lab will support customers’ genomic testing needs and expand the company’s digital health services, will enable Sema4 to perform scientific research, and will create hundreds of jobs.